Publications
178
Citations
5,031
Est. group size
~38
Recurring co-author estimate
Active years
26
Publishing since 2001
Raju R. Raval's research focuses on radiation oncology, particularly the treatment of brain tumors such as glioblastoma and other central nervous system cancers, as well as radiosensitization strategies that make tumors more responsive to radiation therapy. His work spans clinical trials combining immunotherapy with radiation and chemotherapy, advanced radiotherapy delivery techniques, and laboratory studies on molecular approaches (such as androgen signaling and RNA-based therapies) to enhance treatment effectiveness in cancers including prostate cancer and glioblastoma.
Publication output has grown substantially over the past decade, rising from single digits in 2017-2018 to over 40 publications in 2023, indicating an increasingly active research program.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- NRG-BN002: Phase I study of ipilimumab, nivolumab, and the combination in patients with newly diagnosed glioblastoma
Neuro-Oncology · 2024
- Volumetric Modulated Arc Therapy Craniospinal Irradiation Utilizing a Vertebral Body Sparing Approach: A Toxicity Analysis
International Journal of Radiation Oncology*Biology*Physics · 2023
- Supplementary Figure 3 from Androgen Deprivation Followed by Acute Androgen Stimulation Selectively Sensitizes AR-Positive Prostate Cancer Cells to Ionizing Radiation
2023
- Supplementary Figure 2 from Androgen Deprivation Followed by Acute Androgen Stimulation Selectively Sensitizes AR-Positive Prostate Cancer Cells to Ionizing Radiation
2023
- Supplementary Figure 1 from Androgen Deprivation Followed by Acute Androgen Stimulation Selectively Sensitizes AR-Positive Prostate Cancer Cells to Ionizing Radiation
2023
- Supplementary Figure Legends from Androgen Deprivation Followed by Acute Androgen Stimulation Selectively Sensitizes AR-Positive Prostate Cancer Cells to Ionizing Radiation
2023
- Supplementary Figure 4 from Androgen Deprivation Followed by Acute Androgen Stimulation Selectively Sensitizes AR-Positive Prostate Cancer Cells to Ionizing Radiation
2023
- Supplementary Figure 1 from Androgen Deprivation Followed by Acute Androgen Stimulation Selectively Sensitizes AR-Positive Prostate Cancer Cells to Ionizing Radiation
2023
- Supplementary Figure 2 from Androgen Deprivation Followed by Acute Androgen Stimulation Selectively Sensitizes AR-Positive Prostate Cancer Cells to Ionizing Radiation
2023
- Data from Androgen Deprivation Followed by Acute Androgen Stimulation Selectively Sensitizes AR-Positive Prostate Cancer Cells to Ionizing Radiation
2023
- Data from Androgen Deprivation Followed by Acute Androgen Stimulation Selectively Sensitizes AR-Positive Prostate Cancer Cells to Ionizing Radiation
2023
- Supplementary Figure Legends from Androgen Deprivation Followed by Acute Androgen Stimulation Selectively Sensitizes AR-Positive Prostate Cancer Cells to Ionizing Radiation
2023
- Supplementary Figure 4 from Androgen Deprivation Followed by Acute Androgen Stimulation Selectively Sensitizes AR-Positive Prostate Cancer Cells to Ionizing Radiation
2023
- Supplementary Figure 3 from Androgen Deprivation Followed by Acute Androgen Stimulation Selectively Sensitizes AR-Positive Prostate Cancer Cells to Ionizing Radiation
2023
- Supplementary Tables 1 and 2 and Supplementary Figures 1 through 3 from Systemic Administration and Targeted Radiosensitization via Chemically Synthetic Aptamer–siRNA Chimeras in Human Tumor Xenografts
2023
- International Journal of Radiation Oncology*Biology*Physics×37
- Neuro-Oncology×20
- Advances in Radiation Oncology×10
- Neuro-Oncology Advances×9
- Journal of Clinical Oncology×8
- Rituraj Upadhyay
Medicine · The Ohio State University
- Raj Singh
Medicine · The Ohio State University
- Haley K. Perlow
Medicine · The Ohio State University
- Sasha Beyer
Medicine · The Ohio State University
- John McGregor
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile